Gilead Sciences
GILD
#81
Rank
S$265.23 B
Marketcap
S$213.84
Share price
-0.41%
Change (1 day)
39.09%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2023 (TTM): S$6.02

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is S-$3.97. In 2022 the company made an earnings per share (EPS) of S$4.70 a decrease over its 2021 EPS that were of S$6.34.

EPS history for Gilead Sciences from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S$6.0228.06%
2022S$4.70-25.86%
2021S$6.344850%
2020S$0.13-97.64%
2019S$5.430.9%
2018S$5.3818.71%
2017S$4.54-64.88%
2016S$12.92-18.45%
2015S$15.8455.28%
2014S$10.20296.02%
2013S$2.5817.89%
2012S$2.18-6.32%
2011S$2.337.69%
2010S$2.1715.75%
2009S$1.8736.45%
2008S$1.3722.99%
2007S$1.11-233.33%
2006S-$0.84-246.63%
2005S$0.5771.15%
2004S$0.33-633.33%
2003S-$0.06246-205.41%
2002S$0.0592629.82%
2001S$0.04565-174.51%
2000S-$0.06126-1.92%
1999S-$0.0624619.18%
1998S-$0.05241-30.38%
1997S-$0.07528141.03%
1996S-$0.03123

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.57-315.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$0.97-124.52%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$4.57-215.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.55-1,095.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$20.78-623.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$3.02-176.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$7.55-290.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$22.21-659.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$1.27-132.02%๐Ÿ‡บ๐Ÿ‡ธ USA